ResMed Ltd. recalls Astral 100 and Astral 150 ventilators
- Recall date
- September 13, 2023
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-0111-2024
- FDA classification
- Class I
- Brand / firm
- ResMed Ltd.
- Sold / distributed
- Worldwide - US Nationwide distribution including in the states of CA, NJ, VA, IN, MI, WV, NY, WI, ND, IL, NC, FL, CO, TX, AL, LA, MD, OR, AZ, MN, WA, PA, SC, MA, ID, GA, SD, TN, NH, OH, MS, CT, IA, KY, UT, NE, MO, NV, AR, WY, RI, KS, VT, ME, OK, PR, MO, DC and the countries of Taiwan, Israel, Spain…
Why it was recalled
If ventilator is on internal battery, not intended to serve as a primary power source, low/critically low battery alarms will sound, but a fault leads to sudden power loss. If power fails, then ventilation stops and a Total Power Failure (TPF) alarm should sound, but it's powered by a supercapacitor, which degrades over time, which may cause TPF alarm to sound for less than 2 minutes or not at all
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
Astral 100 and Astral 150 ventilators
Get recall alerts
Free email alert whenever ResMed Ltd. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: ResMed Ltd.